Septoplasty evidence for nasal obstruction is most useful when it answers a practical question: is a deviated septum actually the reason a person cannot breathe well enough through the nose, and would straightening it address that problem? A septum can be visibly off-centre without causing troublesome symptoms, while persistent blockage can arise from several structures or from inflammation. Septoplasty is therefore not a cosmetic shortcut and not a treatment to choose from a photograph. It is a functional operation considered after a clinician connects a person’s symptoms, examination and likely cause of obstruction.
The strongest modern septoplasty evidence for nasal obstruction comes from the NAIROS randomised trial, which compared surgery with a defined course of saline and steroid nasal sprays in adults with at least moderate symptoms linked to septal deviation. At six months, the group assigned to septoplasty reported substantially better sinonasal outcomes on average. That is meaningful evidence for carefully selected adults, but it is not a guarantee that surgery will solve every blocked nose. Good care begins by distinguishing a septal problem from nasal valve collapse, enlarged turbinates, rhinitis, sinus disease, sleep-related symptoms and other contributors.
What septoplasty changes—and what it does not
The septum is the internal partition made of cartilage and bone that separates the two nasal passages. It is common for it not to sit exactly in the middle. A bend, spur or more complex deviation can narrow one side, alter airflow through both sides, or make other narrow areas more important. Septoplasty reshapes, repositions or removes selected deviated portions of that internal framework while preserving enough support for the nose. It is performed to improve function, form, or both when the anatomy and symptoms justify it.
By itself, septoplasty does not reshape the external nose in the way cosmetic rhinoplasty does. Nor is it the same operation as nasal valve repair or turbinate reduction, although either may be considered at the same time when the assessment supports it. This distinction protects patients from a common oversimplification: a deviated septum may be one part of an airway problem, but it is not automatically the whole explanation. The related research guide on functional rhinoplasty and the overlap between airway and cosmetic goals explains why the operative label must follow the diagnosis rather than replace it.
Symptoms provide a starting point, not a diagnosis
Septal obstruction often feels like persistent difficulty through one side of the nose, but symptoms vary. Some people notice it during exercise, at night, after a cold, or when lying on a particular side. Others report recurrent crusting, nosebleeds, a sense of poor airflow or a history of nasal injury. The normal nasal cycle can also make one side feel temporarily more open than the other, so a changing sensation alone does not prove a fixed obstruction.
A clinician should ask when the problem began; whether there has been trauma, prior nasal surgery, allergy or seasonal variation; what medications have been tried; and whether there are symptoms such as facial pain, discharge, reduced smell, sleep disturbance or frequent nosebleeds. Allergic and non-allergic rhinitis can swell the lining and create congestion even when the septum is deviated. Nasal polyps, chronic sinus disease and medication effects can also matter. These conditions may need medical treatment or a different work-up; they should not be dismissed simply because a septal bend is visible.
How clinicians assess a deviated septum
The 2015 AAO-HNSF Clinical Consensus Statement on septoplasty supports a history of nasal obstruction together with a corresponding physical examination as the central basis for decision-making. Anterior rhinoscopy lets the clinician inspect the front of the nose. Nasal endoscopy is not required to prove every deviation, but it can be useful when the history and initial findings do not match, or when another cause of obstruction may coexist. It can help identify issues such as polyps, chronic inflammation, scar-related narrowing or posterior obstruction that a front-of-nose view may not explain fully.
Assessment also includes the inferior turbinates—normal structures that condition inspired air but may be enlarged—and the nasal valve, the narrowest functional region of the nasal airway. A person can have a deviated septum plus valve collapse, where the sidewall narrows or moves inward during inspiration. The AAO-HNS position statement on nasal valve repair emphasises that septoplasty, turbinate reduction and valve surgery are not interchangeable treatments. If the main problem is valve dysfunction, straightening the septum alone may leave a patient disappointed; if the deviation is the dominant restriction, valve surgery may be unnecessary.
Imaging is not a routine substitute for this clinical assessment. A scan can be helpful for selected sinus or trauma questions, but it does not automatically determine whether septoplasty will improve a person’s symptoms. Nor can online photographs, a mirror test or a self-performed manoeuvre diagnose the cause. The practical article can rhinoplasty improve breathing? offers a patient-friendly introduction, while a face-to-face assessment is where the individual anatomy has to be interpreted.
The NAIROS trial: what the best comparative evidence found
For many years, septoplasty was widely performed, but high-quality comparisons with non-surgical treatment were limited. The Nasal Airway Obstruction Study (NAIROS) addressed that gap in a multicentre, open-label randomised trial in the United Kingdom. It enrolled 378 adults with at least moderately severe nasal obstruction associated with septal deviation. Participants were assigned either to septoplasty, with or without unilateral inferior turbinate surgery at the surgeon’s discretion, or to defined medical management using a saline spray and a topical steroid spray for six months.
The primary outcome was the Sino-nasal Outcome Test-22 (SNOT-22), a patient-reported questionnaire in which lower scores reflect fewer symptoms. At six months, the intention-to-treat analysis found scores about 20 points lower on average in the surgical arm than in the medical-management arm (adjusted difference −20.01; 95% confidence interval −23.63 to −16.40). The difference exceeded the trial’s prespecified nine-point threshold for a clinically important change. Outcomes remained in favour of septoplasty at 12 months, although the between-group difference was smaller. The trial also found a pattern of larger average benefit among participants who began with more severe symptoms.
This is a stronger finding than an uncontrolled before-and-after series because randomisation helps reduce the chance that baseline differences alone explain the result. It supports offering septoplasty to adults whose obstruction is at least moderate, is associated with a deviated septum and has been evaluated in a specialist setting. It does not establish that every person with a mild deviation needs an operation, that sprays never help, or that an individual outcome can be predicted from the group average.
What “medical management” meant in NAIROS
The comparison in NAIROS was specific: isotonic saline plus a nasal steroid spray, used as a defined regimen. This is important because medical treatment can be very helpful when mucosal inflammation, allergic rhinitis or another inflammatory condition is driving congestion. It may also be a sensible initial step when symptoms are intermittent, the diagnosis is uncertain or a person prefers to avoid surgery. It is not expected to straighten a fixed cartilage or bone deviation, but reducing lining swelling can clarify how much of the obstruction remains structural.
The NAIROS investigators did not define one universal duration or sequence of medical treatment that every patient everywhere must complete before discussing surgery. Clinical decisions should account for symptom severity, examination, previous appropriate treatment, coexisting disease and the patient’s priorities. A thoughtful consultation should explain whether medical care is being recommended because it is likely to address inflammation, because the structural contribution is unclear, or because its lower risk is appropriate for the current level of symptoms.
Who the evidence applies to
The NAIROS results apply most directly to adults with at least moderate nasal obstruction associated with septal deviation who were assessed in participating secondary-care ENT services. The average participant was about 40 years old; the trial population was predominantly male and white. These details do not invalidate the evidence for other adults, but they do limit how precisely it can be generalised across ages, populations and types of obstruction. Children, people with complex post-traumatic deformity, prior extensive nasal surgery or a primary nasal-valve problem may require different evidence and a more individual discussion.
Severity matters, but it is not the only criterion. A person may have a dramatic-looking deviation with little inconvenience and reasonably choose observation. Another may have a less obvious deviation but persistent symptoms that affect work, exercise and sleep. The goal is not to operate on an image of a septum; it is to make an informed decision about a symptom burden that corresponds to treatable anatomy. Patient-reported measures such as NOSE and SNOT-22 can document baseline burden and later change, but they complement rather than replace examination.
Septoplasty in the functional-rhinoplasty spectrum
Septoplasty is often described alongside functional rhinoplasty because both are concerned with nasal airflow. The overlap is real, but they should not be collapsed into one promise. Septoplasty targets the internal partition. Functional rhinoplasty may address the internal or external nasal valve, sidewall weakness, scar-related narrowing or loss of structural support, sometimes using grafts or sutures. Turbinate procedures address a separate structure. In a combined plan, each component should have a named purpose.
This is especially relevant when a person also wants cosmetic rhinoplasty. External straightening can sometimes require septal work, and correcting a deviated septum can occasionally affect external balance. Yet a cosmetic reduction, narrower bridge or tip refinement is not proof of functional treatment. Conversely, a functional plan can alter appearance. The patient should understand which steps are intended to address breathing, which serve appearance, which serve both, and what trade-offs remain. A careful explanation is more useful than the claim that one operation will automatically solve every concern.
Risks, recovery and uncertainty
Septoplasty is commonly performed, but it is still surgery. Possible complications include bleeding, infection, a septal haematoma, persistent or recurrent obstruction, crusting, adhesions, a septal perforation, changes in smell, numbness around the upper teeth or lip, and—rarely—an alteration in the external shape or support of the nose. Some problems need observation or medical treatment; others may require a further procedure. Risk depends on the anatomy, the extent of surgery, healing, coexisting conditions and surgical technique, so a patient’s own consent discussion must be specific.
Early swelling, congestion and crusting can make breathing feel temporarily worse before it improves. Follow-up is part of treatment, not an afterthought: it allows the surgical team to assess healing, manage crusting or infection if they occur, and reconsider symptoms that do not track with the expected recovery. Urgent heavy bleeding, fever, increasing pain, marked swelling or a concerning change in vision warrants prompt medical advice rather than waiting for a routine visit.
Limits of the evidence and of the operation
NAIROS was pragmatic and open label, which suits a real surgical decision but means participants knew whether they had surgery. The operation could include turbinate reduction, and many people allocated to medical management did not remain on their assigned path through the full follow-up period. Those features do not erase the clear six-month signal, but they mean the trial cannot isolate every surgical component or promise a particular result for one anatomy. The study also measured symptoms and quality of life, which are essential outcomes, while objective airflow measurements do not always mirror how open a patient feels.
Septoplasty does not cure allergy, chronic inflammatory rhinitis, every sleep concern, snoring or obstructive sleep apnoea. It may be one useful part of care when obstruction is structural, but it is not a substitute for evaluation of symptoms outside the nose. The questions in what to ask before rhinoplasty are equally relevant to functional planning: ask what is being treated, what evidence supports the recommendation, what alternatives exist and how outcomes will be followed.
Questions to bring to a septoplasty consultation
- What findings connect my symptoms to a septal deviation?
- Could turbinate enlargement, rhinitis, sinus disease or nasal valve collapse also be contributing?
- What medical treatment is appropriate in my situation, and what would it be expected to change?
- Would the planned operation include turbinate treatment or valve repair, and why?
- How will my breathing be measured or discussed before and after surgery?
- What risks are more relevant to my anatomy, prior treatment and health history?
Bottom line
Septoplasty has credible randomised-trial evidence for selected adults with at least moderate nasal obstruction associated with a deviated septum. In NAIROS, surgery outperformed a defined saline-and-steroid-spray regimen on average at six months, with benefit sustained at 12 months. The evidence supports diagnosis-led surgery, not a blanket recommendation for every deviated septum. The safest interpretation is straightforward: identify the cause of obstruction, treat inflammation when it is relevant, distinguish the septum from the turbinates and nasal valve, and use surgery when the expected functional benefit justifies its risks and limits.
